169 related articles for article (PubMed ID: 35455475)
1. 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.
Catarzi D; Varano F; Vigiani E; Calenda S; Melani F; Varani K; Vincenzi F; Pasquini S; Mennini N; Nerli G; Dal Ben D; Volpini R; Colotta V
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455475
[TBL] [Abstract][Full Text] [Related]
2. Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A
Catarzi D; Varano F; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Volpini R; Colotta V
Pharmaceuticals (Basel); 2019 Oct; 12(4):. PubMed ID: 31652622
[TBL] [Abstract][Full Text] [Related]
3. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A
Nkomba G; Terre'Blanche G; Janse van Rensburg HD; Legoabe LJ
Med Chem Res; 2022; 31(8):1277-1297. PubMed ID: 35634433
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A
Hamilton LJ; Pattabiraman M; Zhong HA; Walker M; Vaughn H; Chandra S
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513829
[TBL] [Abstract][Full Text] [Related]
6. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
7. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
8. Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity.
Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; di Cesare Mannelli L; Ghelardini C; Lucarini E; Dal Ben D; Spinaci A; Bartolucci G; Menicatti M; Colotta V
J Med Chem; 2019 Aug; 62(15):6894-6912. PubMed ID: 31306001
[TBL] [Abstract][Full Text] [Related]
9. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
Front Chem; 2018; 6():206. PubMed ID: 29998095
[TBL] [Abstract][Full Text] [Related]
10. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
[TBL] [Abstract][Full Text] [Related]
11. The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A
Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Colotta V
Eur J Med Chem; 2018 Apr; 150():127-139. PubMed ID: 29525433
[TBL] [Abstract][Full Text] [Related]
12. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A
Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V
Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470
[TBL] [Abstract][Full Text] [Related]
13. Identification of new potent A
Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J
Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A
Varano F; Catarzi D; Vigiani E; Dal Ben D; Buccioni M; Marucci G; Di Cesare Mannelli L; Lucarini E; Ghelardini C; Volpini R; Colotta V
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358083
[TBL] [Abstract][Full Text] [Related]
15. Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.
Matos MJ; Vilar S; Kachler S; Fonseca A; Santana L; Uriarte E; Borges F; Tatonetti NP; Klotz KN
ChemMedChem; 2014 Oct; 9(10):2245-53. PubMed ID: 25044491
[TBL] [Abstract][Full Text] [Related]
16. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
17. Probing Adenosine and P2 Receptors: Design of Novel Purines and Nonpurines as Selective Ligands.
Jacobson KA
Drug Dev Res; 2001; 52(1-2):178-186. PubMed ID: 38239932
[TBL] [Abstract][Full Text] [Related]
18. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
19. Identification of V6.51L as a selectivity hotspot in stereoselective A
Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of adenosine analogues with indole moiety as human adenosine A
Xia Y; Zheng X; Wang E; Li D; Hou R; Wang J
R Soc Open Sci; 2018 Feb; 5(2):171596. PubMed ID: 29515872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
